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have contributed remarkably to the suste-
nance and growth of the livestock industry 
(Schwarz and Chaslus-Dancla 2001). As a 
result of the benefits derivable from antim-
icrobials usage, these drugs have been used 
without restriction in livestock production. 
ABSTRACT 
The emergence and wide-spread dissemination of antimicrobial resistant bacteria strains is a global 
phenomenon of great public health and economic implications. Antimicrobial resistance was investi-
gated in enterobacteriaceae isolated from apparently healthy and diseased poultry birds using the 
broth micro-dilution method to determine antimicrobial minimum inhibitory concentration (MIC). In all, 
504 bacterial isolates including Escherichia coli (471), Klebsiella spp (28) and Salmonella enterica 
isolates (5) were studied. The isolates were resistant to ampicillin (88.5%), chloramphenicol (62.3%), 
ciprofloxacin (74.8%), enrofloxacin (81.0%), neomycin (83.9%), norfloxacin (78.8%), streptomycin 
(91.3%) and tetracycline (83.3%). The geometric mean MIC (µg/µL) of tested antimicrobials for en-
terobacteriaceae is as follows: ampicillin (102.5), chloramphenicol (48.4), ciprofloxacin (19.1), enro-
floxacin (34.5), neomycin (47.7), norfloxacin (24.5), streptomycin (142.2) and tetracycline (62.5). Al-
though rates of resistance to ampillin, streptomycin and tetracycline were similar among isolates from 
apparently healthy and diseases birds, resistance to chloramphenicol, ciprofloxacin, enrofloxacin, neo-
mycin and norfloxacin were significantly higher (p<0.05) in isolates from diseased chickens than in 
those from apparently healthy chickens. The high rates of antimicrobial resistance in bacteria may 
contribute to the persistence of pathogens in poultry flock and ineffectiveness of antimicrobial chemo-
therapy during disease outbreaks. 
 
Keywords: Antimicrobial resistance, apparently healthy chickens, diseased chickens, diseased tur-
keys, enterobacteriaceae 
 
INTRODUCTION 
Antimicrobials are important drugs for the 
prevention and treatment of bacterial infec-
tions in humans and animals (Schwarz and 
Chaslus-Dancla 2001; DANMAP, 2011). 
The introduction and use of antimicrobials 
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Many livestock producers depend on antim-
icrobials to cover-up for unhygienic and 
inadequate management practices that ex-
pose animals to potential pathogens and 
increase their susceptibility to infections 
(Soulsby, 2007; Silbergeld et al., 2008). Of-
tentimes, antimicrobials are administered 
without due consideration for the possible 
deleterious effects they exert on the micro- 
and macro- ecosystem (WHO, 2007). 
 
Over the years, the continuous use of an-
timicrobials has boomerang into a situation 
where the continued efficacy of these drugs 
is under threat due to the occurrence of 
highly resistant bacteria strains which are 
refractory to antimicrobial therapy (Barbosa 
and Levy, 2000). The increasing widespread 
emergence and dissemination of these multi
-drug resistant bacteria is a result of the 
combined effects of overdependence on 
antimicrobials, inadequate management 
practices, climate change, globalization and 
international trade (Harbarth and Samore, 
2005; MacPherson et al., 2009). Globally, 
there is an increase in reports of resistant 
bacteria of human and animal origins. The 
socio-economic consequences associated 
with increased morbidity and mortality 
from refractory infections have reached 
such a magnitude that calls for concerted 
efforts by all local and international stake-
holders in tackling the problem of antim-
icrobial resistance in bacteria (WHO, 2001).  
Escherichia coli is an important pathogen in 
humans and animals. Pathogenic E. coli is 
capable of causing devastating intestinal and 
extra-intestinal diseases in infected hosts 
(Nataro and Kaper, 1998). Escherichia coli is a 
major cause of morbidity and mortality in 
poultry and can be transmitted to humans 
through the consumption of contaminated 
poultry products (van den Bograad et al., 
2001; Stordeur et al., 2002; Kabir, 2010). 
The organism is also used as an indicator 
bacterium for the surveillance of antimicro-
bial resistance in the ecosystem and also for 
tracing faecal contamination of food prod-
ucts, hence, the possible presence of other 
pathogenic bacteria (Momtaz et al., 2012; 
Bergeron et al., 2012). Antimicrobial resis-
tance in commensal E. coli plays important 
roles in the maintenance and dissemination 
of resistant traits in the community (Kijima-
Tanaka et al., 2003). Drug-resistant E. coli 
may serve as important reservoirs of resis-
tant genes for pathogenic and non-
pathogenic recipient bacterial species 
(Osterloh, 2004; Sunde and Norström 2006). 
Surveillance programmes for monitoring an-
timicrobial resistance in bacteria are impor-
tant in the development of strategies for the 
prevention and control of antimicrobial re-
sistance. However, in the developing coun-
tries, scarcity of data complicates attempts to 
assess the magnitude of threat to the live-
stock industry public health by resistant bac-
teria.  Inadequate documentation of observ-
able trends in antimicrobial resistance ham-
pers risk assessment and development of 
suitable interventions to mitigate the menace 
of antimicrobial resistance in developing 
countries. 
 
The present study investigates the incidence 
of antimicrobial resistance in E. coli, Klebsiella 
spp and Salmonella serotypes bacteria isolated 
from apparently healthy and diseased inten-
sively-reared chickens and turkeys in Abeo-
kuta, Nigeria. 
 
MATERIALS AND METHODS 
Sampling information 
Between March 2008 and December 2011, 
samples were collected from seven poultry 
farms for bacteria isolation and determina-
tion of antimicrobial susceptibility.  
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Sampling from apparently healthy 
chickens: 
 Faecal samples were collected from appar-
ently healthy, intensively raised commercial 
layer chickens from five farms. The birds 
were in battery cages and had history of 
previous vaccination against Infectious Bur-
sal Disease, Newcastle Disease, Marek’s 
Disease and Fowl Pox. In addition, regular 
prophylactic antimicrobial and booster 
Newcastle Disease vaccine administrations 
were common practices in all the farms. 
Pooled cloacal swabs were collected from 
live birds on the farms. Five cloacal swabs 
were pooled as one sample. Sixty pooled 
samples (300 cloacal swabs) were collected 
from each farm. Pooled faecal sampling was 
used because it increases the chance of in-
clusion of faecal materials from infected 
birds which may contain high numbers of 
organisms and thus compensate for the 
possible low level present in other birds 
(Carrique-Mas and Davies, 2008; Varga et 
al., 2008). Chickens sampled were randomly 
selected among the flock. A total of 300 
pooled faecal samples were thus collected 
from five farms. 
 
Sampling from sick birds: 
Clinical samples (diarrhoeic faeces and tis-
sue samples) from two farms with history 
of diarrhoea were examined. One of the 
farms was a commercial layer farm with 
adult laying chickens. The other farm was a 
broiler farm with young chicks and turkey 
poults of four to six weeks old. Bacterial 
infections were suspected in both cases 
(after ruling out viral and protozoan in-
volvement) and samples submitted for bac-
teriology. Cloacal swabs were collected 
from individual live sick birds. Post mortem 
tissue samples from liver, lung and spleen 
samples were aseptically collected for bacte-
riological examination. From the commer-
cial layer farms, 78 cloacal swabs and 60 tis-
sue samples (20 each of liver, lung and 
spleen) were examined. From the broiler 
farm, 62 cloacal swabs and 33 tissue samples 
(11 each of liver, lung and spleen) were col-
lected from diarrhoeic and dead chicks while 
96 cloacal swabs and 60 tissue samples (20 
each of liver, lung and spleen) were collected 
from diarrhoeic and dead poults. 
 
Bacteria isolation and identification: 
Faecal samples were each inoculated directly 
onto MacConkey agar (CM 0115 Oxoid® 
Basingstoke, UK) while tissue samples were 
first inoculated into Tryptic Soy Broth (TSB) 
for enrichment before being transferred onto 
MacConkey agar and 5% blood agar. Cul-
tures were incubated at 37oC for 18 to 24 
hours. After incubation, agar plates were ex-
amined for bacterial growth. Discrete colo-
nies of bacteria were identified and selected. 
Selected colonies were purified on MacCon-
key agar and blood agar, Gram-stained for 
microscopy and tested for catalase and cyto-
chrome oxidase production. Colonies that 
yielded oxidase negative, catalase positive, 
Gram-negative rods were subjected to fur-
ther identification using biochemical tests 
kits (Oxoid Microbact GNB 24E®) and reac-
tions interpreted by using accompanying 
computer software package (Oxoid Micro-
bact® 2000 version 2.03). 
 
Antimicrobial susceptibility testing 
The bacteria isolated from samples were 
tested for susceptibility to antimicrobial 
agents. Susceptibility to ampicillin (Amp), 
chloramphenicol (Chl), ciprofloxacin (Cip), 
enrofloxacin (Enr), neomycin (Neo), nor-
floxacin (Nor), streptomycin (Str) and tetra-
cycline (Tet) were determined by the broth 
micro-dilution technique to determine the 
minimum inhibitory concentration (MIC) 
using antimicrobial concentrations ranging 
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from 0.25-512 µg/µL according to the stan-
dard guidelines by Clinical and Laboratory 
Standards Institute (2008). The antimicro-
bial MIC were determined with reference to 
the respective antimicrobial breakpoint con-
centrations for bacterial isolates (ampicillin, 
32 µg/µL; chloramphenicol, 32 µg/µL; 
ciprofloxacin, 4 µg/µL ; enrofloxacin, 4 µg/
µL; neomycin, 16 µg/µL; norfloxacin, 4 µg/
µL; streptomycin, 64 µg/µL and tetracy-
cline, 16 µg/µL) (CLSI, 2008). Isolates with 
minimum inhibitory concentrations (MIC) 
higher than the breakpoint for the respec-
tive antimicrobial agents were regarded as 
resistant while those with MIC equal to or 
lower than the breakpoint were regarded as 
susceptible. 
 
Statistical Analysis:  
Data were expressed in absolute values and 
in percentages. The geometric mean of MIC 
values were determine using Microsoft Of-
fice Excel 2007 software package. Rates of 
antimicrobial resistance were compared be-
tween isolated from apparently healthy and 
diseased birds by Chi-square test at p<0.05 
probability level using Statistical Software 
Package for Social Sciences (SPSS, version 
16, 2007). 
 
RESULTS 
A total of 504 bacterial isolates belonging to 
three genera in the family Enteroobateriaceae 
were obtained in this study. The isolates 
comprised of E. coli (471), Klebsiella spp (28) 
and Salmonella enterica (5) (Table 1). Overall, 
the isolates showed resistance to ampicillin 
(88.5%), chloramphenicol (62.3%), cipro-
floxacin (74.8%), enrofloxacin (81.0%), 
neomycin (83.9%), norfloxacin (78.8%), 
streptomycin (91.3%) and tetracycline 
(83.3%) (Table 1). Rates of resistance to 
chloramphenicol, ciprofloxacin, enroflox-
acin, neomycin and norfloxacin were signifi-
cantly higher (p<0.05) in bacterial isolates 
from diseased chickens than in those from 
apparently healthy chickens. However, there 
was no significant difference (p˃0.05) in the 
rates of antimicrobial resistance in isolates 
from diseased chickens and turkeys.  
 
Antimicrobial resistance in bacterial iso-
lates from apparently healthy commercial 
chickens 
The rates of antimicrobial resistance in E. coli 
isolates from commercial chickens is am-
picillin 74.4%, chloramphenicol 37.8%, 
ciprofloxacin 36.1%, enrofloxacin 48.8%, 
neomycin 57.6%, norfloxacin 46.5%, strep-
tomycin 76.7% and tetracycline 57.6%. The 
geometric mean MIC was highest (121.5 µg/
µL) for streptomycin and lowest (3.0 µg/µL) 
for norfloxacin (Table 2). 
 
Klebsiella isolates from apparently healthy 
commercial chickens showed resistance to 
ampicillin (75.0%), chloramphenicol (25.0%), 
ciprofloxacin (12.5%), enrofloxacin (37.5%), 
neomycin (50.0%), norfloxacin (12.5%), 
streptomycin (62.5%) and tetracycline 
(62.5%). The geometric mean MIC was high-
est (152.2 µg/µL) for ampicillin and lowest 
(0.5 µg/µL) for ciprofloxacin (Table 3). 
 
All the five Salmonella isolates from appar-
ently healthy commercial chicken were resis-
tant to ampicillin, four (80.0%) were resistant 
to streptomycin, two (40.0%) showed resis-
tance to each of chloramphenicol, enroflox-
acin and neomycin while only one (20.0%) 
was resistant to each of ciprofloxacin, nor-
floxacin and tetracycline. The geometric 
mean MIC was highest (168.9 µg/µL) for 
ampicillin and lowest (0.5 µg/µL) for cipro-
floxacin (Table 4). 
 
115 
O. E. OJO1*, O. O. ONI2, O. O. OGUNJOBI1, J. O. OKUBOYE1, O. G. OGUNYINKA1 AND M. A. OYEKUNLE 
J. Nat. Sci. Engr. Tech. 2012, 11(1): 112-128 
Ta
bl
e 
1: 
 A
nt
im
ic
ro
bi
al
 re
si
st
an
ce
 in
 b
ac
te
ria
l i
so
la
te
s f
ro
m
 a
pp
ar
en
tly
 h
ea
lth
y 
an
d 
di
se
as
ed
 c
hi
ck
en
s a
nd
 tu
rk
ey
s i
n 
 
   
   
   
   
   
Ab
eo
ku
ta
, N
ig
er
ia
 
Ba
ct
er
ia
l i
so
lat
es
 b
y 
so
ur
ce
 (n
um
be
r 
te
st
ed
) 
N
um
be
r (
%
) o
f r
es
ist
an
t i
so
la
te
s 
A
m
pi
ci
lli
n 
Ch
lo
ra
m
-
ph
en
ic
ol
 
Ci
pr
of
lo
x-
ac
in
 
E
nr
of
lo
xa
ci
n 
N
eo
m
yc
in
 
N
or
flo
xa
ci
n 
St
re
pt
om
yc
in
 
Te
tra
cy
cl
in
e 
E
sc
he
ric
hi
a 
co
li 
  
  
  
  
  
  
  
  
A
pp
ar
en
tly
 h
ea
lth
y 
ch
ic
ke
ns
 (1
72
) 
12
8.
0 
(7
4.
4)
 
65
.0
 (3
7.
8)
 
62
.0
 (3
6.
1)
 
84
.0
 (4
8.
8)
 
99
.0
 (5
7.
6)
 
80
.0
 (4
6.
5)
 
13
2.
0 
(7
6.
7)
 
99
.0
 (5
7.
6)
 
D
ise
as
ed
 c
hi
ck
en
s 
(1
94
) 
19
4.
0 
(1
00
.0
) 
14
6.
0 
(7
5.
3)
 
19
4.
0 
(1
00
.0
) 
19
4.
0 
(1
00
.0
) 
19
4.
0 
(1
00
.0
) 
19
4.
0 
(1
00
.0
) 
19
4.
0 
(1
00
.0
) 
19
4.
0 
(1
00
.0
) 
D
ise
as
ed
 T
ur
ke
ys
 
(1
05
) 
94
.0
 ( 
89
.5
) 
83
.0
 (7
9.
1)
 
10
1.
0 
(9
6.
2)
 
10
5.
0 
(1
00
.0
) 
10
5.
0 
(1
00
.0
) 
10
1.
0 
(9
6.
2)
 
10
5.
0 
(1
00
.0
) 
10
1.
0 
(9
6.
2)
 
Su
bt
ot
al
 (4
71
) 
41
6 
(8
8.
3)
 
29
4 
(6
2.
4)
 
35
7 
(7
5.
8)
 
38
3 
(8
1.
3)
 
39
8 
(8
4.
5)
 
37
5 
(7
9.
6)
 
43
1 
(9
1.
5)
 
39
4 
(8
3.
7)
 
K
le
bs
ie
lla
 sp
ec
ie
s 
  
  
  
  
  
  
  
  
A
pp
ar
en
tly
 h
ea
lth
y 
ch
ic
ke
ns
 (8
) 
6.
0 
(7
5.
0)
 
2.
0 
(2
5.
0)
 
1.
0 
(1
2.
5)
 
3.
0 
(3
7.
5)
 
4.
0 
(5
0.
0)
 
1.
0 
(1
2.
5)
 
5.
0 
(6
2.
5)
 
5.
0 
(6
2.
5)
 
D
ise
as
ed
 c
hi
ck
en
s 
(1
5)
 
14
.0
 (9
3.
3)
 
12
.0
 (8
0.
0)
 
14
.0
 (9
3.
3)
 
15
.0
 (1
00
.0
) 
14
.0
 (9
3.
3)
 
15
.0
 (1
00
.0
) 
15
.0
 (1
00
.0
) 
15
.0
 (1
00
.0
) 
D
ise
as
ed
 T
ur
ke
ys
 
(5
) 
5.
0 
(1
00
.0
) 
4.
0 
(8
0.
0)
 
4.
0 
(8
0.
0)
 
5.
0 
(1
00
.0
) 
5.
0 
(1
00
.0
) 
5.
0 
(1
00
.0
) 
5.
0 
(1
00
.0
) 
5.
0 
(1
00
.0
) 
Su
bt
ot
al
 (2
8)
 
25
 (8
9.
3)
 
18
 (6
4.
3)
 
19
 (6
7.
9)
 
23
 (8
2.
1)
 
23
 (8
2.
1)
 
21
 (7
5.
0)
 
25
 (8
9.
3)
 
25
 (8
9.
3)
 
Sa
lm
on
el
la 
 
se
ro
ty
pe
s 
  
  
  
  
  
  
  
  
A
pp
ar
en
tly
 h
ea
lth
y 
ch
ic
ke
ns
 (5
) 
5.
0 
(1
00
.0
) 
2.
0 
(4
0.
0)
 
1.
0 
(2
0.
0)
 
2.
0 
(4
0.
0)
 
2.
0 
(4
0.
0)
 
1.
0 
(2
0.
0)
 
4.
0 
(8
0.
0)
 
1.
0 
(2
0.
0)
 
D
ise
as
ed
 c
hi
ck
en
s 
- 
- 
- 
- 
- 
- 
- 
- 
D
ise
as
ed
 T
ur
ke
ys
 
- 
- 
- 
- 
- 
- 
- 
- 
Su
bt
ot
al
 (5
) 
5.
0 
(1
00
.0
) 
2.
0 
(4
0.
0)
 
1.
0 
(2
0.
0)
 
2.
0 
(4
0.
0)
 
2.
0 
(4
0.
0)
 
1.
0 
(2
0.
0)
 
4.
0 
(8
0.
0)
 
1.
0 
(2
0.
0)
 
O
ve
ra
ll 
to
ta
l (
50
4)
 
44
6 
(8
8.
5)
 
31
4 
(6
2.
3)
 
37
7 
(7
4.
8)
 
40
8 
(8
1.
0)
 
42
3 
(8
3.
9)
 
39
7 
(7
8.
8)
 
46
0 
(9
1.
3)
 
42
0 
(8
3.
3)
 
ANTIMICROBIAL RESISTANCE IN ENTEROBACTERIACEAE FROM... 
116 J. Nat. Sci. Engr. Tech. 2012, 11(1): 112-128 
Ta
bl
e 
2:
 M
in
im
um
 i
nh
ib
ito
ry
 c
on
ce
nt
ra
tio
n 
of
 a
nt
im
ic
ro
bi
al
 a
ge
nt
s 
fo
r 
E
sc
he
ric
hi
a 
co
li 
is
ol
at
ed
 f
ro
m
 a
pp
ar
en
tly
 
he
al
th
y 
 
A
nt
im
ic
ro
bi
al
 
ag
en
ts
 
N
um
be
r 
of
 is
o-
la
te
 
te
st
ed
 
Ra
ng
e 
of
 te
st
ed
 
an
tim
ic
ro
bi
al
 
co
nc
en
tra
tio
n 
(µ
g/
 µ
L
) 
Lo
w
es
t 
M
IC
 
 (µ
g/
 µ
L
) 
H
ig
he
st
 
M
IC
 (
µg
/ 
µL
) 
G
eo
m
et
ric
 
m
ea
n 
M
IC
 
(µ
g/
 µ
L
) 
M
IC
50
 
(µ
g/
 µ
L
) 
M
IC
90
 
(µ
g/
 µ
L
) 
N
um
be
r (
%
)  
se
ns
iti
ve
 
N
um
be
r (
%
) 
re
sis
ta
nt
 
A
m
pi
ci
lli
n 
17
2 
0.
25
-5
12
 
0.
5 
>
51
2.
0 
73
.1
 
12
8.
0 
51
2.
0 
44
.0
 (2
5.
6)
 
12
8.
0 
(7
4.
4)
 
Ch
lo
ra
m
-
ph
en
ic
ol
 
17
2 
0.
25
-5
12
 
≤
0.
25
 
>
51
2.
0 
22
.3
 
16
.0
 
25
6.
0 
10
7.
0 
(6
2.
2)
 
65
.0
 (3
7.
8)
 
Ci
pr
of
lo
xa
ci
n 
17
2 
0.
25
-5
12
 
≤
0.
25
 
>
51
2.
0 
4.
3 
2.
0 
64
.0
 
11
0.
0 
(6
3.
9)
 
62
.0
 (3
6.
1)
 
E
nr
of
lo
xa
ci
n 
17
2 
0.
25
-5
12
 
≤
0.
25
 
>
51
2.
0 
5.
4 
2.
0 
64
.0
 
88
.0
 (5
1.
2)
 
84
.0
 (4
8.
8)
 
N
eo
m
yc
in
 
17
2 
0.
25
-5
12
 
≤
0.
25
 
>
51
2.
0 
17
.7
 
32
.0
 
25
6.
0 
73
.0
 (4
2.
4)
 
99
.0
 (5
7.
6)
 
N
or
flo
xa
ci
n 
17
2 
0.
25
-5
12
 
≤
0.
25
 
>
51
2.
0 
3.
0 
2.
0 
32
.0
 
92
.0
 (5
3.
5)
 
80
.0
 (4
6.
5)
 
St
re
pt
om
yc
in
 
17
2 
0.
25
-5
12
 
1.
0 
>
51
2.
0 
12
1.
5 
25
6.
0 
51
2.
0 
40
.0
 (2
3.
3)
 
13
2.
0 
(7
6.
7)
 
Te
tra
cy
cl
in
e 
17
2 
0.
25
-5
12
 
≤
0.
25
 
>
51
2.
0 
16
.1
 
16
.0
. 
51
2.
0 
73
.0
 (4
2.
4)
 
99
.0
 (5
7.
6)
 
Ta
bl
e 
3:
 M
in
im
um
 in
hi
bi
to
ry
 c
on
ce
nt
ra
tio
n 
of
 a
nt
im
ic
ro
bi
al
 a
ge
nt
s f
or
 K
le
bs
ie
lla
 sp
p 
is
ol
at
ed
 fr
om
 a
pp
ar
en
tly
 h
ea
lth
y 
 
   
   
   
   
   
in
te
ns
iv
el
y-
re
ar
ed
 c
hi
ck
en
s i
n 
Ab
eo
ku
ta
, N
ig
er
ia
 
A
nt
im
ic
ro
bi
al
 
ag
en
ts
 
N
um
be
r 
of
 is
ol
at
e 
te
st
ed
 
Ra
ng
e 
of
 te
st
ed
 
an
tim
ic
ro
bi
al
 
co
nc
en
tra
tio
n 
Lo
w
es
t 
M
IC
 (
µg
/ 
µL
) 
H
ig
he
st
 
M
IC
 (
µg
/ 
µL
) 
G
eo
m
et
ric
 
m
ea
n 
M
IC
 
(µ
g/
 µ
L
) 
M
IC
50
 
(µ
g/
 µ
L
) 
M
IC
90
 
(µ
g/
 µ
L
) 
N
um
be
r 
(%
)  
se
ns
iti
ve
 
N
um
be
r (
%
) 
re
sis
ta
nt
 
A
m
pi
ci
lli
n 
8 
0.
25
-5
12
 
51
2.
0 
51
2.
0 
15
2.
2 
51
2.
0 
51
2.
0 
2.
0 
(2
5.
0)
 
6.
0 
(7
5.
0)
 
Ch
lo
ra
m
ph
en
ic
ol
 
8 
0.
25
-5
12
 
16
.0
 
25
6.
0 
26
.9
 
16
.0
 
25
6.
0 
6.
0 
(7
5.
0)
 
2.
0 
(2
5.
0)
 
Ci
pr
of
lo
xa
ci
n 
8 
0.
25
-5
12
 
0.
25
 
4.
0 
0.
5 
0.
25
 
4.
0 
7.
0 
(8
7.
5)
 
1.
0 
(1
2.
5)
 
E
nr
of
lo
xa
ci
n 
8 
0.
25
-5
12
 
2.
0 
8.
0 
2.
0 
2.
0 
8.
0 
5.
0 
(6
2.
5)
 
3.
0 
(3
7.
5)
 
N
eo
m
yc
in
 
8 
0.
25
-5
12
 
16
.0
 
32
.0
 
10
.4
 
16
.0
 
32
.0
 
4.
0 
(5
0.
0)
 
4.
0 
(5
0.
0)
 
N
or
flo
xa
ci
n 
8 
0.
25
-5
12
 
1.
0 
4.
0 
1.
2 
1.
0 
4.
0 
7.
0 
(8
7.
5)
 
1.
0 
(1
2.
5)
 
St
re
pt
om
yc
in
 
8 
0.
25
-5
12
 
12
8.
0 
12
8.
0 
69
.8
 
12
8.
0 
12
8.
0 
3.
0 
(3
7.
5)
 
5.
0 
(6
2.
5)
 
Te
tra
cy
cl
in
e 
8 
0.
25
-5
12
 
12
8.
0 
12
8.
0 
26
.9
 
12
8.
0 
12
8.
0 
3.
0 
(3
7.
5)
 
5.
0 
(6
2.
5)
 
O. E. OJO1*, O. O. ONI2, O. O. OGUNJOBI1, J. O. OKUBOYE1, O. G. OGUNYINKA1 AND M. A. OYEKUNLE 
117 J. Nat. Sci. Engr. Tech. 2012, 11(1): 112-128 
Ta
bl
e 
4:
 M
in
im
um
 in
hi
bi
to
ry
 c
on
ce
nt
ra
tio
n 
of
 a
nt
im
ic
ro
bi
al
 a
ge
nt
s f
or
 S
al
m
on
el
la
 se
ro
ty
pe
s i
so
la
te
d 
fro
m
 a
pp
ar
en
tly
 
   
   
   
   
  h
ea
lth
y 
in
te
ns
iv
el
y-
re
ar
ed
 c
hi
ck
en
s i
n 
Ab
eo
ku
ta
, N
ig
er
ia
 
A
nt
im
icr
ob
ial
 
ag
en
ts
 
N
um
be
r 
of
 is
ol
at
e 
te
st
ed
 
Ra
ng
e 
of
 te
st
ed
 
an
tim
icr
ob
ial
 
co
nc
en
tra
tio
n 
Lo
w
es
t 
M
IC
 
(µ
g/
 µ
L
) 
H
ig
he
st
 
M
IC
 
(µ
g/
 µ
L
) 
G
eo
m
et
-
ric
 m
ea
n 
M
IC
 
(µ
g/
 µ
L
) 
M
IC
50
 
(µ
g/
 µ
L
) 
M
IC
90
 
(µ
g/
 µ
L
) 
N
um
be
r 
(%
)  
se
ns
iti
ve
 
N
um
be
r 
(%
)  
re
sis
ta
nt
 
A
m
pi
cil
lin
 
5 
0.
25
-5
12
 
64
.0
 
>
51
2.
0 
16
8.
9 
12
8.
0 
51
2.
0 
0.
0 
(0
.0
) 
5.
0 
(1
00
.0
) 
Ch
lo
ra
m
-
ph
en
ico
l 
5 
0.
25
-5
12
 
0.
5 
12
8.
0 
13
.9
 
8.
0 
12
8.
0 
3.
0 
(6
0.
0)
 
2.
0 
(4
0.
0)
 
Ci
pr
of
lo
xa
cin
 
5 
0.
25
-5
12
 
≤
0.
25
 
8.
0 
0.
5 
0.
25
 
8.
0 
4.
0 
(8
0.
0)
 
1.
0 
(2
0.
0)
 
E
nr
of
lo
xa
cin
 
5 
0.
25
-5
12
 
0.
5 
25
6.
0 
5.
3 
1.
0 
25
6.
0 
3.
0 
(6
0.
0)
 
2.
0 
(4
0.
0)
 
N
eo
m
yc
in
 
5 
0.
25
-5
12
 
4.
0 
>
51
2.
0 
16
.0
 
4.
0 
51
2.
0 
3.
0 
(6
0.
0)
 
2.
0 
(4
0.
0)
 
N
or
flo
xa
cin
 
5 
0.
25
-5
12
 
≤
0.
25
 
16
.0
 
0.
9 
0.
5 
16
.0
 
4.
0 
(8
0.
0)
 
1.
0 
(2
0.
0)
 
St
re
pt
om
yc
in
 
5 
0.
25
-5
12
 
16
.0
 
>
51
2.
0 
14
7.
0 
25
6.
0 
51
2.
0 
1.
0 
(2
0.
0)
 
4.
0 
(8
0.
0)
 
Te
tra
cy
cli
ne
 
5 
0.
25
-5
12
 
0.
5 
12
8.
0 
6.
1 
4.
0 
12
8.
0 
4.
0 
(8
0.
0)
 
1.
0 
(2
0.
0)
 
ANTIMICROBIAL RESISTANCE IN ENTEROBACTERIACEAE FROM... 
118 J. Nat. Sci. Engr. Tech. 2012, 11(1): 112-128 
Antimicrobial resistance in bacterial iso-
lates from diseased chickens: 
All 194 E. coli isolates from diseased chick-
ens were all resistant to tested antimicrobi-
als except chloramphenicol to which 146 
(75.3%) of the isolates were resistant. The 
geometric mean MIC was highest (156.4 
µg/µL) in ampicillin and least (38.1 µg/µL) 
in ciprofloxacin (Table 5).  
 
Klebsiella isolates from diseased chickens 
showed 100% resistance to enrofloxacin, 
norfloxacin, streptomycin and tetracycline; 
93.3% resistance to ciprofloxacin, ampicillin 
and neomycin and 80.0% resistance to 
chloramphenicol. The geometric mean MIC 
was highest (406.4 µg/µL) in ampicillin and 
least (46.3 µg/µL) in ciprofloxacin (Table 
6). 
 
Antimicrobial resistance in bacterial iso-
lates from diseased turkeys: 
Escherichia coli isolates from diseased turkeys 
were all resistant to enrofloxacin, neomycin 
and streptomycin. The rate of resistance to 
ciprofloxacin, norfloxacin and tetracycline 
was 96.2% each while resistance was 89.5% 
and 79.1% for ampicillin and chlorampheni-
col respectively. The geometric mean MIC 
was highest (146.1 µg/µL) in streptomycin 
and least (95.7 µg/µL) in norfloxacin (Table 
7). 
 
All five (100%) Klebsiella isolates from dis-
eased turkeys were resistant to ampicillin, 
enrofloxacin, neomycin, norfloxacin and tet-
racycline while four (80.0%) were resistant to 
chloramphenicol and ciprofloxacin. The geo-
metric mean MIC was highest (512.0 µg/µL) 
in ampicillin and least (55.7 µg/µL) in cipro-
floxacin (Table 8). 
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DISCUSSION 
In the present study, E. coli was the pre-
dominant isolate from apparently healthy 
and diseased poultry birds. This agrees with 
earlier report by Kilonzo-Nthenge et al. 
(2008) that E. coli is a major cause of mor-
bidity and mortality in poultry worldwide 
(Kilonzo-Nthenge et al., 2008). Apart from 
being a primary cause of diseases, E. coli is 
also implicated as an opportunistic patho-
gen capable of complicating infections 
caused by other pathogens. Other bacteria 
identified in the present study (Salmonella 
enterica isolates  and Klebsiella spp.) are also 
known to induce clinical diseases in poultry 
(Kilonzo-Nthenge et al., 2008). Salmonella 
species was the least encountered and was 
detected only in apparently healthy chick-
ens. Although a major avian pathogen of 
high economic importance, the presence of 
Salmonella in apparently healthy birds 
showed that birds may harbour Salmonella 
without clinical manifestations (Agbaje et al., 
2010). Apparently healthy carriers may thus 
serve as sources of persistent Salmonella in-
fection in the flock. 
 
The present study showed varying degrees 
of antimicrobial resistance in bacterial spe-
cies isolated from apparently healthy chick-
ens in the study area. In all the bacteria spe-
cies, the highest rates of antimicrobial resis-
tance and geometric mean MIC were re-
corded in ampicillin and streptomycin. Am-
picillin and streptomycin are first generation 
antimicrobials which are  commonly used 
antimicrobials in the livestock industry. This 
may account for the higher rates of resis-
tance to these drugs. Generally, there was 
moderate level of neomycin resistance 
which did not exceed 50.0% except in E. 
coli (57.6%). Among the antimicrobials from 
different classes represented in this study, 
resistance to the fluoroquinolones was rela-
tively low. However, it is evident that bacte-
ria are developing resistance to the fluoro-
quinolone which are considered the drug of 
choice for the treatment of gastroenteritis in 
humans (Guerrant et al., 2001). Among 
fluoroquinolones (ciprofloxacin, enroflox-
acin and norfloxacin) resistance rate and geo-
metric mean MIC were observed to be high-
est for enrofloxacin and lowest for ciproflox-
acin. Enrofloxacin resistance rate was as high 
as 48.8% in E. coli and ciprofloxacin resis-
tance as low as 12.5% in Klebsiella spp.  A 
previous study in Nigeria  showed that enro-
floxacin is the most commonly administered 
fluoroquinolones in poultry production in 
the study area (Ogunleye et al., 2008). This 
may be responsible for the higher rates of 
resistance to enrofloxacin than to other 
fluoroquinolones. Fluoroquinolone resistant 
avian E. coli has been reported in other re-
gions of the world (White et al., 2000; Thor-
steinsdottir et al., 2010; Chen et al., 2011) and 
may be transmitted to humans through the 
food chain (Warren et al., 2008). The contin-
ued efficacy of fluoroquinolone therapy in 
the treatment of human diseases can be 
achieved by regulating the use of these drugs 
in humans and disallowing their use in food 
animals (Cheng et al., 2012). 
 
The presence of drug resistant bacteria in 
apparently healthy chicken as observed in 
the present study has implications for poul-
try production and public health. Non-
pathogenic resistant bacteria resident in ap-
parently healthy birds may share their resis-
tant trait and confer resistance on virulent 
pathogens or acquire virulent traits from 
pathogenic bacteria (Yaron et al., 2000; Os-
terloh, 2004). Exchange of resistance and 
virulence genes is common among enteric 
bacteria especially the enterobacteriaceae 
(Balis et al., 1996; Yaron et al., 2000). Close 
contact between humans and birds, con-
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sumption of contaminated poultry products 
and environmental contamination may in-
crease the possible transmission of resistant 
bacteria more so it has been reported that 
transmission of resistant clones and plas-
mids from poultry to humans is a common 
occurrence (Van dan Boggard et al., 2001).   
 
The overall high rates of antimicrobial resis-
tance observed among the bacterial isolates 
in this study were due largely to high resis-
tance observed in isolates from diseased 
birds. When considered separately, resis-
tance rates were significantly lower (p<0.05) 
in isolates from apparently healthy birds 
than in isolates from diseased birds. The 
present study suggests that antimicrobial 
resistant bacteria may predominate in dis-
ease outbreaks. Antimicrobial resistant Sal-
monella spp. have been reported to be more 
invasive than susceptible strains thereby 
producing more severe and fatal infections 
(Helms et al., 2004). The present study in-
vestigated outbreaks of diarrhoea refractory 
to antimicrobial therapy accompanied by 
high mortality of over 60%. Escherichia coli 
was isolated from all the clinical samples 
submitted for bacteriological examination. 
Few isolates of Klebsiella spp were also ob-
tained from the samples. High levels of an-
timicrobial resistance of between 80.0% and 
100% (100% in most cases) were observed 
among the bacterial isolates. Involvement 
of multi-drug resistant bacteria in disease 
outbreak as observed in the present study 
could undermine the efficacy of therapeutic 
intervention in the control of bacterial in-
fections. The direct effect of orally adminis-
tered drug on enteric bacteria may alter the 
integrity of gastrointestinal microflora lead-
ing to the eradication of susceptible strains 
and proliferation of resistant ones (Zhoa et 
al., 2001). This may lead to an increase in 
the prevalence of antimicrobial resistance in 
isolates recovered from animals while on 
antimicrobial therapy. In the present study, 
antimicrobial agents had been administered 
to the sick birds before sample collection 
and as such may account for the high level 
of antimicrobial resistance in the bacterial 
isolates (Boothe and Debavalya 2011).  An-
timicrobial usage during an outbreak may 
therefore eliminate competing susceptible 
bacteria co-habiting the gut with resistant 
pathogens. This will aid the proliferation of 
the resistant pathogen and increase the dam-
age done to the host. The high rates of an-
timicrobial resistance in bacteria may also 
contribute to the persistence of pathogens in 
poultry flock because of the ineffectiveness 
of chemoprophylactic eradication approach. 
 
  CONCLUSION 
 
The present study showed high level of an-
timicrobial resistance in clinical and non-
clinical bacterial isolates from intensively 
reared birds in the study area. The major fac-
tors selecting for antimicrobial resistance in 
bacteria are antimicrobial use, overcrowding 
and poor sanitation. These factors are typical 
of many intensive poultry farming and may 
explain the high prevalence of antimicrobial 
resistance in bacteria as encountered in this 
study. Antimicrobial resistance in avian bac-
terial pathogens is a threat to profitable poul-
try production, protein availability and public 
health.   
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